Large-scale pharmacogenomic study of sulfonylureas and the QT, JT, and QRS intervals: CHARGE Pharmacogenomics Working Group

Sulfonylureas, a commonly-used class of medication used to treat type 2 diabetes, have been associated with an increased risk of cardiovascular disease. Their effects on QT interval duration and related electrocardiographic phenotypes are potential mechanisms for this adverse effect. In eleven ethni...

Descripción completa

Detalles Bibliográficos
Autores principales: Floyd, James S, Sitlani, Colleen M, Avery, Christy L, Noordam, Raymond, Li, Xiaohui, Smith, Albert V, Gogarten, Stephanie M, Li, Jin, Broer, Linda, Evans, Daniel S, Trompet, Stella, Brody, Jennifer A, Stewart, James D, Eicher, John D, Seyerle, Amanda A, Roach, Jeffrey, Lange, Leslie A, Lin, Henry J, Kors, Jan A, Harris, Tamara B, Li-Gao, Ruifang, Sattar, Naveed, Cummings, Steven R, Wiggins, Kerri L, Napier, Melanie D, Stürmer, Til, Bis, Joshua C, Kerr, Kathleen F, Uitterlinden, André G, Taylor, Kent D, Stott, David J, de Mutsert, Renée, Launer, Lenore J, Busch, Evan L, Méndez-Giráldez, Raúl, Sotoodehnia, Nona, Soliman, Elsayed Z, Li, Yun, Duan, Qing, Rosendaal, Frits R, Slagboom, P Eline, Wilhelmsen, Kirk C, Reiner, Alexander P, Chen, Yii-Der I, Heckbert, Susan R, Kaplan, Robert C, Rice, Kenneth M, Jukema, J Wouter, Johnson, Andrew D, Liu, Yongmei, Mook-Kanamori, Dennis O, Gudnason, Vilmundur, Wilson, James G, Rotter, Jerome I, Laurie, Cathy C, Psaty, Bruce M, Whitsel, Eric A, Cupples, L Adrienne, Stricker, Bruno H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468495/
https://www.ncbi.nlm.nih.gov/pubmed/27958378
http://dx.doi.org/10.1038/tpj.2016.90

Ejemplares similares

Ejemplares similares